Assertio News

Assertio to Participate in Benchmark Healthcare Conference on May 21-22

LAKE FOREST, Ill., May 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated

GlobeNewswireMay 17 09:15 ET

Express News | Buxton Helmsley Group: Urges Assertio Stockholders to Vote Against All Directors at Upcoming Annual Meeting

ReutersMay 17 07:31 ET

Assertio to Participate in AGP Healthcare Conference on May 21

LAKE FOREST, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated

GlobeNewswireMay 16 09:16 ET

Express News | Buxton Helmsley Says It Urges Assertio Stockholders to Immediately Cast Votes "Against" All of Assertio Director Nominees - SEC Filing

ReutersMay 14 17:47 ET

Express News | Buxton Helmsley Group Says Has Demanded Two Seats on Assertio Board

ReutersMay 13 17:56 ET

Express News | Buxton Helmsley: Believes That Assertio's Board Should Initiate a Modest, but Material Share Repurchase Program

ReutersMay 13 17:56 ET

Express News | Buxton Helmsley: Believes Assertio Board Should Promptly Explore Strategic Alternatives, Including a Possible Sale

ReutersMay 13 17:54 ET

Express News | Buxton Helmsley Group: Urges Assertio Holdings Stockholders to Vote Against All Company's Director Nominees at Company's Upcoming 2024 Annual Meeting

ReutersMay 13 17:53 ET

Assertio to Present at the Citizens JMP Life Sciences Conference in New York City

LAKE FOREST, Ill., May 10, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated

GlobeNewswireMay 10 15:12 ET

Assertio Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceMay 8 06:45 ET

Express News | Assertio Holdings Shares Are Trading Lower. The Company Reported Q1 Financial Results

BenzingaMay 7 12:30 ET

Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 7 10:28 ET

Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Longboard Pharmaceuticals (LBPH) and Travere Therapeutics (TVTX)

TipRanksMay 7 09:00 ET

Q1 2024 Assertio Holdings Inc Earnings Call

Yahoo FinanceMay 7 05:35 ET

Assertio Holdings Inc (ASRT) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...

Yahoo FinanceMay 7 03:10 ET

Assertio Holdings, Inc. (ASRT) Q1 2024 Earnings Call Transcript

Assertio Holdings, Inc. (ASRT) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 6 19:07 ET

Assertio | 10-Q: Quarterly report

Futu NewsMay 6 17:00 ET · Announcements

Express News | Assertio Reiterates Guidance For 2024, Calling For Net Product Sales Of $110M-$125M (Est $117.35M) And Adjusted EBITDA Of $20M-$30M

BenzingaMay 6 16:37 ET

Earnings Flash (ASRT) ASSERTIO HOLDINGS Posts Q1 EPS $0.04, Vs. Street Est of $-0.01

04:08 PM EDT, 05/06/2024 (MT Newswires) -- Earnings Flash (ASRT) ASSERTIO HOLDINGS Posts Q1 EPS $0.04, vs. Street Est of $-0.01

MT NewswiresMay 6 16:08 ET

Assertio Holdings: Reiterating Guidance for 2024, Calling for Net Pdt Sales of $110M to $125M and Adjusted EBITDA of $20M to $30M >ASRT

Assertio Holdings: Reiterating Guidance for 2024, Calling for Net Pdt Sales of $110M to $125M and Adjusted EBITDA of $20M to $30M >ASRT

Dow JonesMay 6 16:03 ET